Silk Road Medical Announces Retirement of CEO Erica Rogers
October 10 2023 - 4:20PM
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on
reducing the risk of stroke and its devastating impact, today
announced that CEO Erica Rogers plans to retire from the Company
following the completion of a succession process. The Company is
working with Spencer Stuart, a leading executive search firm. To
ensure a smooth transition, Ms. Rogers will remain as President and
CEO of the Company until her successor is appointed.
“I’d like to thank Erica for her tremendous contributions to
Silk Road over the last 11 years. Erica has been integral in
leading and expanding the Company’s strong operational
infrastructure and commercial enterprise and driving a significant
expansion of the use of Transcarotid Artery Revascularization
(TCAR) and its impact on patients. She also has created an
enduring, mission-focused culture at Silk Road, setting the Company
apart,” said Jack Lasersohn, Chairman of the Board. “The Silk Road
Medical senior leadership team and Board of Directors are
well-prepared for Erica’s transition. We plan to work closely
together to ensure a smooth process as we drive continued growth in
the business.”
“It has been an honor to work with the Silk Road team through
more than a decade of progress toward improving patients’ lives,”
said Ms. Rogers. “I’m incredibly proud of the foundation we’ve
built, our amazing employees, and our undeniable leadership in
carotid artery disease innovation. We have set the stage for an
exciting future for the Company. I look forward to supporting a
smooth transition and cheering on our team as they continue to
promote TCAR as the gold standard in stroke prevention.”
About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device
company located in Sunnyvale, California, and Plymouth, Minnesota,
that is focused on reducing the risk of stroke and its devastating
impact. The company has pioneered a new approach for the treatment
of carotid artery disease called TransCarotid Artery
Revascularization (TCAR). TCAR is a clinically proven procedure
combining surgical principles of neuroprotection with minimally
invasive endovascular techniques to treat blockages in the carotid
artery at risk of causing a stroke. For more information on how
Silk Road Medical is delivering brighter patient outcomes through
brighter clinical thinking, visit www.silkroadmed.com and connect
on Twitter, LinkedIn and Facebook.
Forward-Looking Statements
Statements contained in this release that relate to future, not
past, events are forward-looking statements under the Private
Securities Litigation Reform Act of 1995, including the anticipated
retirement of Erica Rogers as CEO and a board member.
Forward-looking statements are based on current expectations of
future events and often can be identified by words such as “plan,”
“expect,” “should,” “project,” “anticipate,” “intend,” “will,”
“can,” “may,” “believe,” “could,” “continue,” “future,” other words
of similar meaning or the use of future dates. Forward-looking
statements by their nature address matters that are, to different
degrees, uncertain. Risks and uncertainties may cause Silk Road
Medical’s actual results to be materially different than those
expressed in or implied by Silk Road Medical’s forward-looking
statements. For Silk Road Medical, such risks and uncertainties
include, among others, risks surrounding the retirement of Ms.
Rogers and the change in management and the Company’s success in
retaining and recruiting key personnel. More detailed information
on these and other factors that could affect Silk Road Medical’s
actual results are described in its filings with the U.S.
Securities and Exchange Commission, including its most recent
quarterly report on Form 10-Q filed with the Securities and
Exchange Commission on August 8, 2023. Silk Road Medical undertakes
no obligation to update its forward-looking statements.
Investor Contact:Marissa BychGilmartin Group
LLCinvestors@silkroadmed.com
Media:Michael FanucchiSilk Road
Medicalmfanucchi@silkroadmed.com
Silk Road Medical (NASDAQ:SILK)
Historical Stock Chart
From May 2024 to Jun 2024
Silk Road Medical (NASDAQ:SILK)
Historical Stock Chart
From Jun 2023 to Jun 2024